HMS Holdings Corp. Announces Q3 2008 Results, 2008 Revised Guidance and Initial 200...(assets (18) (171...),Health

Decrease in accounts payable,

accrued expenses and

other liabilities (2,679) (267)

Net cash provided by

operating activities 15,823 13,793

Investing activities:

Purchases of property and

equipment (4,908) (6,772)

Acquisition of BSPA - (15,000)

Acquisition of Prudent Rx (4,030) -

Investment in software (735) (473)

Net cash used in

investing activities (9,673) (22,245)

Financing activities:

Proceeds from exercise of stock options 1,647 3,840

Tax benefit of disqualifying

dispositions 7,251 5,108

Repayment of long-term debt (4,725) (6,300)

Net cash provided by

financing activities 4,173 2,648

Net increase/(decrease) in cash

and cash equivalents 10,323 (5,804)

Cash and cash equivalents at beginning

of period 21,275 12,527

Cash and cash equivalents at end of

period $31,598 $6,723

Supplemental disclosure of cash flow

information:

Cash paid for income taxes $1,813 $47

Cash paid for interest $979 $1,458

Supplemental disclosure of noncash

investing activities:

Accrued purchase price rela
'/>"/>